Bassel Alsaed

Bassel Alsaed

Auto-generated profile, based on publicly available information

Bassel Alsaed

Translational Immunology Research Program (TRIMM), Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
BABassel Alsaed
Bassel Alsaed
LLLinh Lin
Linh Lin
JSJieun Son
Jieun Son
JLJiaqi Li
Jiaqi Li
JSJohannes Smolander
Johannes Smolander
HHHeidi M. Haikala
Heidi M. Haikala
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors are commonly used to treat non-small cell lung cancers with EGFR mutations, but drug resistance often emerges. Intratumor heterogeneity is a known cause of targeted therapy resistance and is considered a major factor in treatment failure. This study identifies clones of EGFR-mutant non-small cell lung tumors expressing low levels of both wild-type and mutant EGFR protein. These EGFR-low cells are intrinsically more tolerant to EGFR inhibitors, more invasive, and exhibit an epithelial-to-mesenchymal-like phenotype compared to their EGFR-high counterparts. The EGFR-low cells secrete Transforming growth factor beta (TGFβ) family cytokines, leading to increased recruitment of cancer-associated fibroblasts and immune suppression, thus contributing to the drug-tolerant tumor microenvironment. Notably, pharmacological induction of EGFR using epigenetic inhibitors sensitizes the resistant cells to EGFR inhibition. These findings suggest that intrinsic drug resistance can be prevented or reversed using combination therapies.

1 November 2024 in Science Advances
Verified
Journal Article
Open access
BABassel Alsaed
Bassel Alsaed
JSJohannes Smolander
Johannes Smolander
HLHanna Laitinen
Hanna Laitinen
LLLinh Lin
Linh Lin
NBNina Bobik
Nina Bobik
HHHeidi M. Haikala
Heidi M. Haikala
Despite immunotherapy’s promise in cancer treatment, patient responses vary substantially because of the individual nature of the immune system and the lack of reliable biomarkers. To address this issue, we developed a precision ex vivo platform that integrates patient-specific tumor and immune cells to study the mechanisms of antitumor immune response, predict immunotherapy outcomes, and identify effective treatments. This platform revealed unique single-cell immune response mechanisms and sensitivities to standard-of-care immunotherapies. Furthermore, we were able to identify a synergistic combination of anti–programmed cell death protein 1 (anti–PD-1) together with a Casitas B lineage lymphoma-b inhibitor that overcame anti–PD-1 resistance in selected patient samples. Activation of the interferon-γ–stimulated cytokines predicted combination efficacy, while immunosuppressive cytokines were associated with poor response. Our findings underscore the platform’s potential in tailoring immunotherapies and advancing drug development, offering avenues for personalized cancer treatment.

12 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JPJennifer T. Pentz
Jennifer T. Pentz
ABAparna Biswas
Aparna Biswas
BABassel Alsaed
Bassel Alsaed
PLPeter A. Lind
Peter A. Lind
Microbial experimental evolution is commonly highly repeatable under identical conditions, indicating a potential for short-term evolutionary forecasting. However, it is unclear to what extent evolutionary predictions can be extrapolated to related species adapting in similar environments, which would enable direct testing of general forecasting models and biological assumptions. To further develop a model system for evolutionary forecasting based on adaptation to static culture conditions, we experimentally tested previous predictions for Pseudomonas syringae and Pseudomonas savastanoi . In addition to sequence divergence, these species also differ in their repertoire of diguanylate cyclases that can be mutationally activated to produce the adaptive wrinkly spreader (WS) phenotype and genes for biosynthesis of exopolysaccharides. After experimental evolution, we isolated 32 independent WS mutants for P. syringae and 37 WS mutants for P. savastanoi that had increased ability to colonize the air-liquid interface and reduced motility. As predicted, most mutants had mutations in the wsp operon followed by rarer promoter mutations upstream of uncharacterized diguanylate cyclases. Surprisingly, no mutations were found in wspF, the most commonly mutated gene in the previously characterized species, which was explained by differences in relative fitness. While prediction of mutated regions was largely successful for WspA, mutations in WspE had a divergent pattern for both species. Surprisingly, deletion of known exopolysaccharide loci previously shown to contribute to the adaptive WS phenotype in other species did not reduce fitness, suggesting the presence of additional adhesive components under c-di-GMP control. This study shows that evolutionary forecasts can be extended to related species, but that differences in the genotype-phenotype-fitness map and mutational biases limit predictability on a detailed molecular level. Author summary: Biological evolution is often observed to be repeatable in the short-term, which suggests that it might be possible to forecast and ultimately steer evolution. Evolutionary processes are fundamental to biology but are also central to major societal problems, including antibiotic resistance, cancer, and adaptation to climate change. Experimental evolution with microbes makes it possible to study evolutionary processes in real-time over many generations to allow direct tests of evolutionary forecasts. However, a fundamental problem is that predictive models are usually based on previous experimental data which limits the novelty of the prediction beyond simple repeatability. A more challenging issue is to predict to what degree similar species evolve in similar ways in similar environments. Here we show that one of the best characterized bacterial experimental evolution model systems, biofilm formation at the surface of static tubes in Pseudomonas , can be extended to related species evolving in similar environments. This allowed us to directly test previous evolutionary forecasts to show that similar phenotypes evolved in similar environments, but that predictions of molecular details often fail. This study also elucidates the causes for failed forecasts to allow continuous improvements in predictive models and to delineate the limits of evolutionary forecasting.